Site Preparation for Establishing 177Lu-Radioligand Therapy Programs There's a New PET Drug in Town: Manufacturing and Approval Consideration for Your Institution Theranostics: Regulatory Considerations for Product Development SNMMI/NCI Third Targeted Radionuclide Therapy Conference 2019
Charging for Investigational Drugs Under an IND - Questions and Answers Guidance for Industry - June 2016 Expanded Access to Investigational Drugs for Treatment Use - Questions and Answers Guidance for Industry - June 2016